PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Advanced Science

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Advanced Science has 1 tracked paper indexed in Blossom (2025) from 18 authors, most often covering LSD and Psilocybin, across Neuroimaging & Brain Measures and Equity and Ethics.

Published Papers

Open Accessindividual

A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness

Using individualised whole‑brain computational modelling fitted to fMRI and diffusion MRI, the authors simulated administration of LSD and psilocybin and applied in silico perturbations to compare states of consciousness and assess treatment effects in disorders of consciousness. Simulated psychedelics shifted patients' brain dynamics closer to criticality—especially in the minimally conscious state—with responses in UWS linked to structural connectivity and in MCS to baseline functional connectivity, providing a computational rationale for psychedelic therapies and personalised prediction.

Published
November 20, 2025
Journal
Advanced Science
Authors
Alnagger, N. L., Cardone, P., Martial, C., Perl, Y. S., Mindlin, I., Sitt, J. D., Roseman, L., Carhart‐Harris, R., Nutt, D., Mallaroni, P., Mason, N., Ramaekers, J. G., Bonhomme, V., Laureys, S., Deco, G., Gosseries, O., Núñez, P., Annen, J.

Quick Facts

Papers Indexed
1

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.